Posted Jun. 14, 2012 at 9:43 a.m.
Drug research
Pharma has become more receptive to cooperative alliances, partnerships and joint ventures with R&D specialists over the last decade, a new report says. They've also refined their therapeutic focus, invested in biologics and taken some prescription products over the counter to accommodate....
Alliances, partnerships, joint ventures to drive more drug development
Post a comment
Print this blog postE-mail blog post
Share
Drug research
Pharma has become more receptive to cooperative alliances, partnerships and joint ventures with R&D specialists over the last decade, a new report says. They've also refined their therapeutic focus, invested in biologics and taken some prescription products over the counter to accommodate....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 MedCity. All rights reserved.Please log in to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
NC Biotech Center braces for worst as Senate slashes budget, too- ArchiveSocial, a new Durham success story, brings home international award
- Durham's high-tech infrastructure, talent lure Virginia company
- Lenovo acknowledges layoffs in Morrisville as part of shift to 'PC Plus' strategy
- Raleigh-based PRA International eyes public offering
- Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
- Raleigh app developer StepLeader lands $4.4M in first fund raiser
- IBM opens Linux center in China, says it will work with Red Hat
- Red-hot Raleigh startup WedPics hauls in $1.1M in funding
- New Triangle venture capital firm slowly emerging from shadows